A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease

  • STATUS
    Recruiting
  • End date
    Jun 14, 2031
  • participants needed
    12
  • sponsor
    Kenai Therapeutics
Send
Updated on 14 November 2025
See if I qualify

Summary

This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.

Details
Condition Idiopathic Parkinson´s Disease, Parkinson's Disease
Age 45years - 75years
Clinical Study IdentifierNCT07106021
SponsorKenai Therapeutics
Last Modified on14 November 2025

Eligibility

 Yes No Not Sure

Inclusion Criteria

Diagnosis of idiopathic Parkinson's disease consistent with the Movement Disorders Society Clinical Criteria
Age 45 to 75
Medically stable to undergo a surgical procedure

Exclusion Criteria

Known Parkinson's disease gene mutation or variant
Previous infusion therapy or surgery for Parkinson's disease
History of allergic reaction or intolerance to an immunotherapeutic agent
Contraindication to MRI
Clinically significant medical conditions likely to interfere with the surgical procedure or study assessments
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.